Kim Sablich Eiger Bio Pharmaceuticals, Inc. (EIGR) insider trading activity

EIGR Quotes by TradingView

Kim Sablich is of Eiger BioPharmaceuticals, Inc.. Currently has a direct ownership of 6,000 shares of EIGR, which is worth approximately $57,000. The most recent transaction as insider was on Mar 11, 2022, when has been sold 6,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6K
0% 3M change
0% 12M change
Total Value Held $57,000

Kim Sablich Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 11 2022
BUY
Grant, award, or other acquisition
-
6,000 Added 50.0%
6,000 Common Stock

Also insider at

JAZZ
Jazz Pharmaceuticals plc Healthcare
EVP, GM of U.S.
KS

Kim Sablich

Dublin 4, L2

Track Institutional and Insider Activities on EIGR

Follow Eiger BioPharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EIGR shares.

Notify only if

Insider Trading

Get notified when an Eiger Bio Pharmaceuticals, Inc. insider buys or sells EIGR shares.

Notify only if

News

Receive news related to Eiger BioPharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EIGR